Evidence map›Paper›PMID 28981715›Full record

ArticleNucleic acids research2017

RNA guanine-7 methyltransferase catalyzes the methylation of cytoplasmically recapped RNAs.

Jackson B Trotman, Andrew J Giltmier, Chandrama Mukherjee, Daniel R Schoenberg

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 77 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. The role of m5C, m1A and m7G modifications in tumors of urinary system.Frontiers in cell and developmental biology · 2025
    Review
  7. Review
  8. RNA modifications and their role in gene expression.Frontiers in molecular biosciences · 2025
    Review
  9. Review
  10. Article
  11. Review
  12. Pan-Cancer Analysis Links Altered RNA mCancer reports (Hoboken, N.J.) · 2024
    Article
  13. Review
  14. Review
  15. Review
  16. A novel serum mFrontiers in genetics · 2024
    Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Jackson B TrotmanCenter for RNA Biology, The Ohio State University, Columbus, OH 43210, USA.
Andrew J GiltmierCenter for RNA Biology, The Ohio State University, Columbus, OH 43210, USA.
Chandrama MukherjeeCenter for RNA Biology, The Ohio State University, Columbus, OH 43210, USA.
Daniel R SchoenbergCenter for RNA Biology, The Ohio State University, Columbus, OH 43210, USA.
The Ohio State University · US

Funding

Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Tasleem J Padamsee · 1985 to 2026
$132.3M
Relationship of Cytoplasmic Capping to Post-transcriptional Gene RegulationR01GM084177 · NIGMS · OHIO STATE UNIVERSITY · PI SCHOENBERG, DANIEL R. · 2010 to 2018
$2.7M
NCI NIH HHS P30 CA016058NIGMS NIH HHS R01 GM084177
6 · The paper itself

Abstract

Cap homeostasis is a cyclical process of decapping and recapping that impacts a portion of the mRNA transcriptome. The metastable uncapped forms of recapping targets redistribute from polysomes to non-translating mRNPs, and recapping is all that is needed for their return to the translating pool. Previous work identified a cytoplasmic capping metabolon consisting of capping enzyme (CE) and a 5'-monophosphate kinase bound to adjacent domains of Nck1. The current study identifies the canonical cap methyltransferase (RNMT) as the enzyme responsible for guanine-N7 methylation of recapped mRNAs. RNMT binds directly to CE, and its presence in the cytoplasmic capping complex was demonstrated by pulldown assays, gel filtration and proximity-dependent biotinylation. The latter also identified the RNMT cofactor RAM, whose presence is required for cytoplasmic cap methyltransferase activity. These findings guided development of an inhibitor of cytoplasmic cap methylation whose action resulted in a selective decrease in levels of recapped mRNAs.

Indexed as

BiocatalysisCell Line, TumorCell NucleusCytoplasmHEK293 CellsHumansMethylationMethyltransferasesRNA-Binding ProteinsRNA CapsMethyltransferasesmRNA (guanine(N7))-methyltransferaseRAMAC protein, humanRNA-Binding ProteinsRNA Caps

Identifiers

PMID28981715
PMCPMC5737702
OpenAlexW2754801371

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.